See inside every stock. Pro
S&P 5007,663▼ 1.21%Nasdaq26,009▼ 2.60%Dow Jones52,868▲ 0.02%Nasdaq 10028,959▼ 2.90%VIX19.03▲ 14.09%US Dollar101.62▼ 0.16%Gold spot4,093▼ 0.80%WTI101.61▲ 2.15%
← BREE page
XStocksXray
Market X-Ray report · 22 October 2026

Breedon Group PLC (BREE)

London Exchange · UK · prices in GBX · close of 22 Oct 2026

Key indicators

Last closeGBX 325.00
52-week range271.40 – 368.00
Return, 1 month / 3 months+5.0% / +2.8%
Return, 1 year / 3 years−1.1% / +16.4%
TrendAbove 200-day, below 50-day
RSI (14)54
Volatility (1 year)30.9%
Worst drawdown (1 year)-21.9%
Average daily value traded346.24M GBX
Dividend yield4.7%

Market X-Ray price-based

66/ 100 · High confidence · ahead of 77% of stocks on this exchange
Trend65
Momentum55
Stability (higher is calmer)64
Liquidity94
Income57

Five-year price chart navy: price · brown: 200-day average

2012663313964612021-102023-012024-042025-072026-10

About the company

Breedon Group is a building materials company based in the United Kingdom. It produces cement, aggregates, asphalt and ready-mixed concrete, and it supplies these materials to customers in the construction industry, including contractors working on housing, commercial projects and infrastructure. The company also operates in Ireland and runs a network of quarries, plants and depots that support its manufacturing and distribution activities across its markets.

On this site Breedon Group PLC appears as a stock on the London Exchange (UK), code BREE, with prices in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Breedon Group PLC (BREE) trades on the London Exchange in UK. It last closed at GBX 325.00 on 22 October 2026.

Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 866 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 1.1% and over the last three months it rose 2.8%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Breedon Group PLC (BREE)

The five lenses in numbers each metric is ranked against the other stocks on London Exchange

Lens and metricValueScoreReading
Trend65 · FairMixed trend against its averages.
Above 200-day average4.3%
From 52-week high-10.2%
Momentum55 · FairTypical recent returns for this exchange.
3-month return2.8%
6-month return6.3%
12-month return, skipping the last month-5.8%
Stability (higher is calmer)64 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)30.9%
Worst drawdown, 1 year (smaller is calmer)-21.9%
Liquidity94 · StrongTrades actively.
Average daily value traded346.24M GBX
Zero-volume days0.0%
Income57 · FairDividend is typical for this exchange.
Dividend yield4.7%
Years with dividends5

Strengths

  • Liquidity: Trades actively.

Weak spots

No lens is weak against its exchange.

Returns

1 week+1.4%
1 month+5.0%
3 months+2.8%
6 months+6.3%
1 year−1.1%
3 years+16.4%
5 years−21.9%

Signals

50-day / 200-day average325.13 / 311.52
Golden / death cross (60 days)Golden, 48 days ago
New 52-week highNo
Bullish RSI divergenceYes
Average daily range (ATR)14.03

Technical summary

DailyStrongly bullish11 bullish · 4 neutral · 1 bearish
WeeklyBullish7 bullish · 1 neutral · 4 bearish
MonthlyBearish2 bullish · 1 neutral · 5 bearish

Recent dividends

Ex-dividend dateAmount per share
1 Oct 2026GBP 0.0500
28 May 2026GBP 0.1025
2 Oct 2025GBP 0.0475
3 Apr 2025GBP 0.1000
26 Sep 2024GBP 0.0450
4 Apr 2024GBP 0.0950

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 23 Oct 2026